CC
JAZZ icon

CQS Cayman’s Jazz Pharmaceuticals JAZZ Stock Holding History

CQS Cayman’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,415
Closed -$985K – 158
2015
Q3 		$985K Sell
7,415
-66,835
-90% -$11.5M 0.08% 117
2015
Q2 		$13.1M Sell
74,250
-12,310
-14% -$2.21M 0.79% 36
2015
Q1 		$15M Buy
+86,560
New +$14.9M 0.7% 29
2014
Q4 		– Sell
-3,115
Closed -$500K – 176
2014
Q3 		$500K Buy
+3,115
New +$479K 0.03% 139

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

CQS Cayman's JAZZ Position: Q4 2015 in Review

CQS Cayman sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 7,415 shares — an estimated $985K sold.

CQS Cayman first reported a position in JAZZ in Q3 2014 and held it in 4 quarters. The position peaked at $15M in Q1 2015. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

  • CQS Cayman reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • CQS Cayman sold 7,415 Jazz Pharmaceuticals shares in Q4 2015, an estimated $985K.
  • CQS Cayman first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • CQS Cayman's Jazz Pharmaceuticals position peaked at $15M in Q1 2015.
  • 345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on CQS Cayman's 13F filing for Q4 2015, filed 11 Feb 2016.